We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Comprehensive Cholesterol Tests Provides Clues for Metabolic Abnormality

By LabMedica International staff writers
Posted on 20 Sep 2010
A detailed lipid profile is helping physicians to diagnose Polycystic Ovarian Syndrome (PCOS), the number one cause of female infertility. More...


The comprehensive cholesterol panel known as the Vertical Auto Profile (VAP) measures 15 separate components of blood cholesterol and can identify a far greater number of lipid abnormalities than standard low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol, and triglycerides.

The VAP test is the only cholesterol test to identify markers for Metabolic Syndrome, a precursor for diabetes. The VAP extended lipid test was developed by Atherotech Diagnostics, (Birmingham, AL, USA) and can report 22 blood "cholesterol” components including accurate measurement of nonfasting direct LDL and all the lipoprotein subclasses.

PCOS increases the risk of heart disease, insulin resistance, diabetes and certain cancers. It is also the most common metabolic abnormality in women of childbearing age, affecting 5-10 million women nationwide. While there is no single test for diagnosing the illness, the detailed cholesterol profile is proving useful. The four major symptoms of PCOS are irregular periods, weight gain, high testosterone levels, and metabolic disorders, including abnormal cholesterol levels. Results have shown a correlation between patients who have PCOS and high levels of total cholesterol and triglycerides, but low levels of high-density lipoprotein 2, a highly protective subclass of HDL.

Steven Foley, M.D., a physician who specializes in PCOS, said, "It is the most accurate and easiest method to evaluate my female patients for elevated cholesterol as well as polycystic ovarian syndrome. It is particularly valuable when developing a treatment plan for women and also helps to monitor response to treatment."

Related Links:

Atherotech




Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.